SHIFT Newsroom · GLOBAL
Trial record: semaglutide and diabetic eye disease
Registry status checked on 3 October 2026: active not recruiting.
ClinicalTrials.gov lists NCT03811561, concerning semaglutide and diabetic eye disease, as active not recruiting. The record was first posted on 2019-01-22 and last updated on 2026-09-09; SHIFT checked it on 3 October 2026. This means the study remains active but is not currently enrolling new participants.
The registration describes a research question and protocol, not proof that the intervention is effective or suitable for an individual.
No results tables were posted in this registry record when checked. That does not establish that no results have been published elsewhere. A registry entry is not a UK marketing authorisation or confirmation of NHS access.
SHIFT’s take
Keep the trial status, published results and UK treatment access separate. Do not change treatment on the basis of a registration.